RLS (USA), Inc., the third-largest nuclear pharmacy network in the US, has announced the appointment of industry veteran Matt Molchan as Senior Vice President of Business Development. Molchan, with over two decades of experience in nuclear medicine and healthcare, will play a key role in driving new business growth for RLS as they expand into new areas such as clinical trials, CDMO work, PET, and patient dose distribution. As the Senior Vice President of Business Development, Molchan will lead the business development strategy for RLS, identifying new opportunities and setting national, regional, and local strategies across the network. He will also be responsible for building partnerships with other industry-leading radiopharmacy firms. Molchan's appointment is seen as a critical step in RLS's expansion plan and establishing strategic partnerships for long-term sustainable growth.
Tue, 05 Sep 2023 13:00:00 GMT | PR Newswire